Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azorix trial of azathioprine/6-mercaptopurine versus infliximab maintenance in Crohn's disease remission
NL-OMON21255Recruiting
- Sponsor
- Academic Medical Center
- Start
- Aug 2008
- Modality
- Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Randomised, open-label trial of infliximab, azathioprine and mercaptopurine in Crohn's disease (2 arms), sponsored by Academic Medical Center. Primary endpoint: Occurrence of relapse. Started Aug 2008; status: recruiting.
02
Drugs
infliximabazathioprinemercaptopurine
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NL-OMON21255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21255.